THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO
UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
CARLSBAD, Calif., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSX-V:ASG) ("Aurora Spine" or the
"Company") is pleased to announce that it will undertake a non-brokered private placement of common shares ("Common Shares") for
gross proceeds of a maximum of CDN$627,300 at a price of CDN$0.10 per share (the "Offering").
In advance of the closing of the Offering, David Rosenkrantz, a director of the Company, will advance an
unsecured, non-convertible loan of USD$125,000 to the Company bearing interest at the rate of rate of 9% per annum. It is expected
that the loan will be repaid from the proceeds of the Offering. The participation of Mr. Rosenkrantz in the Offering constitutes a
related party transaction under Canadian Multilateral Instrument 61-101 ("MI 61-101"), but is otherwise exempt from the formal
valuation and minority approval requirements of MI 61-101.
The net proceeds from the Offering will be used for general working capital purposes.
The Company expects that the Offering will close in late January 2018. All securities issued by Aurora Spine in
connection with this Offering will be subject to a statutory four month hold period. The Offering is subject to certain conditions
including, but not limited to, the receipt of all necessary approvals, including the final approval of the TSX Venture
Exchange.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any of the
securities in the United States. The securities have not been and will not be registered under the United States Securities Act of
1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States
or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such
registration is available.
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a
series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine continues to
position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies.
Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company’s commitment to – Simplifying
the Complex.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and
uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk
Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus
(collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the
Offering and the proposed use of proceeds of the Offering. Aurora Spine cautions investors of Aurora Spine's securities about
important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking
statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans,
objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve
estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed
in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and,
accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only
as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events
or circumstances.
For more information, please contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Sarina Mason
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
